Home/Filings/4/0001628280-24-014735
4//SEC Filing

Hamilton James C 4

Accession 0001628280-24-014735

CIK 0000879407other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 6:05 PM ET

Size

5.6 KB

Accession

0001628280-24-014735

Insider Transaction Report

Form 4
Period: 2024-04-01
Hamilton James C
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2024-04-01$28.03/sh6,000$168,180204,851 total
Footnotes (2)
  • [F1]The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $ 27.97 to $ 28.10, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
  • [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.

Issuer

ARROWHEAD PHARMACEUTICALS, INC.

CIK 0000879407

Entity typeother

Related Parties

1
  • filerCIK 0001830755

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:05 PM ET
Size
5.6 KB